Aptose Biosciences Inc. (APS.TO) TSX
2.20
-0.06(-2.65%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.78M |
| Enterprise Value | 27.7M |
| P/E Ratio | 0.79 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | 0.52 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -425,316 |
| EBITDA | -24.73M |
| Net Income | -25.91M |
| Diluted EPS | -10.59 |
Balance Sheet
| Total Cash | 4.11M |
| Total Cash/Share | 0.4 |
| Total Debt | 34.26M |
| Total Debt/Equity | -0 |
| Current Ratio | 0.55 |
| Book Value Per Share | -13.58 |
Price History
| 52-Week Change | -7.17 |
| 52-Week High | 2.59 |
| 52-Week Low | 1.02 |
| Moving Average 50 Days | 2.3 |
| Moving Average 200 Days | 2.07 |
Statistics
| Average Volume | 3,431 |
| Shares Outstanding | 2.55M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 26, 2025 |
